"Life in Crisis tells the story of Médecins Sans Frontières (Doctors Without Borders or MSF) and its effort to 'save lives' on a global scale. Begun in 1971 as a French alternative to the Red Cross, the MSF has grown into an international institution with a reputation for outspo…
Two professors of government analyze both political disasters and successes of recent decades to provide telling lessons on how to use history to improve decision-making. A dozen case studies are drawn in pungent detail both from the record and from backstage information gained …
This alternative world health report offers a comprehensive survey of the key areas that influence the health of poor and vulnerable groups in all countries. They range from climate change, water and nutrition to national health policies and services and the brain drain of healt…
This alternative world health report offers a comprehensive survey of the key areas that influence the health of poor and vulnerable groups in all countries. They range from climate change, water and nutrition to national health policies and services and the brain drain of healt…
This alternative world health report offers a comprehensive survey of the key areas that influence the health of poor and vulnerable groups in all countries. They range from climate change, water and nutrition to national health policies and services and the brain drain of healt…
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.))
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Nicholson, Anna, English, Rebecca A., Guenther, Rita S., Claiborne, Anne B., Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Global Drug Supply Chain for Secondline Anti-tuberculosis Drugs, Washington, D.C.)
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
This fully revised and updated edition begins with insights into the scope, importance and continuing growth opportunities in the nutraceutical and functional food industries and explores the latest regulatory changes and their impacts. The book demonstrates the global scenario …
Over the last several years, the debate about publics seems to have newly emerged. This debate critically reflects the Habermasian ideal of a (national) public sphere in a transnational context. However, it seems that the issue of a reconstruction of a global public sphere is mo…
Over the last several years, the debate about publics seems to have newly emerged. This debate critically reflects the Habermasian ideal of a (national) public sphere in a transnational context. However, it seems that the issue of a reconstruction of a global public sphere is …
The last 10 years have seen a seismic shift in therapeutic product development and testing. In both the pharmaceutical (both small and large molecule) and medical device sectors, the vast majority of testing and evaluation of products is not performed within innovator companies,…